Beyond checkpoint inhibitors: the three generations of immunotherapy
Clinical and Experimental Medicine · 21.01.2025 · 25 (1)
DOI: 10.1007/s10238-024-01546-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Medicine, online erschienen am 21.01.2025. Verfasst von John Schaub und 1 weiteren Autor:innen. Beteiligte Einrichtung: Woodlands Medical Specialists, 4724 N Davis Hwy, Pensacola, FL, 32503, USA. Hauptthemen laut MEDLINE: Immunotherapy, Immune Checkpoint Inhibitors, Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Woodlands Medical Specialists, 4724 N Davis Hwy, Pensacola, FL, 32503, USA.
- LSU-LCMC Cancer Center, LSU School of Medicine, 1700 Tulane Avenue, Room 510, New Orleans, LA, 70112, USA. stang2@lsuhsc.edu.
Zitieren
APA
Schaub, J., & Tang, S. C. (2025). Beyond checkpoint inhibitors: the three generations of immunotherapy. Clinical and Experimental Medicine, 25(1). https://doi.org/10.1007/s10238-024-01546-2
Vancouver
Schaub J, Tang SC. Beyond checkpoint inhibitors: the three generations of immunotherapy. Clinical and Experimental Medicine. 2025;25(1). doi:10.1007/s10238-024-01546-2
BibTeX
@article{Schaub2025,
author = {Schaub, John and Tang, Shou-Ching},
title = {Beyond checkpoint inhibitors: the three generations of immunotherapy},
journal = {Clinical and Experimental Medicine},
year = {2025},
volume = {25},
number = {1},
doi = {10.1007/s10238-024-01546-2}
}
EUVIMED